 |
|
USE OF ANTIHISTAMINIC DRUGS IN CONTROL OF ATROPINE DERMATITIS AND CONJUNCTIVITIS
F. BRUCE FRALICK, M.D.;
ROBERT D. KIESS, M.D.
Arch Ophthal. 1949;41(5):583-586.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings. |
|
|
|
PHARMACEUTICAL chemists have long attempted to produce a satisfactory substitute for atropine sulfate. The desire to synthesize a substitute cycloplegic and mydriatic not related to the atropine series has been furthered by the fact that contact dermatitis and conjunctivitis occasionally develop in patients using atropine in treatment of iridocyclitis. This reaction may reach such serious proportions that it is necessary to discontinue administration of the drug. The management of the allergic manifestations usually requires discontinuation of the atropine, with substitution of homatropine, scopolamine or duboisine and the application of cold wet compresses. These substitute drugs present two disadvantages. First, none of the drugs produces a sufficiently strong cycloplegic or mydriatic action to be effective in the treatment of acute iridocyclitis. Second, the patient who is sensitized to atropine frequently demonstrates hypersensitivity to these substitute drugs, since they too belong to the atropine series.
The absence of an adequate substitute for
. . . [Full Text PDF of this Article]
Author Affiliations
ANN ARBOR, MICH.
From the Department of Ophthalmic Surgery, University of Michigan.
Footnotes
The various doses of the antihistaminic drugs were determined with the advice of J. H. Sheldon, M.D., Chief of the Division of Allergy, Department of Internal Medicine, University of Michigan.
The diphenhydramine (benadryl®) solution used was supplied by Parke, Davis & Company, Detroit; the tripelennamine (antistin®) solution, by Ciba Pharmaceutical Products, Inc., Lafayette Park, Summit, N. J.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
|
